Skip to main content
  • Register
  • Help
  • Contact us

Abcam plc (ABC) Ord 0.2p

Sell:1,455.00p Buy:1,459.00p 0 Change: 8.00p (0.55%)
FTSE AIM 100:0.33%
Market closed Prices as at close on 23 April 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:1,455.00p
Buy:1,459.00p
Change: 8.00p (0.55%)
Market closed Prices as at close on 23 April 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:1,455.00p
Buy:1,459.00p
Change: 8.00p (0.55%)
Market closed Prices as at close on 23 April 2021 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Abcam plc is a global life sciences company. The Company identifies, develops, and provides biological reagents and tools, which are required in a range of fields and applications including drug discovery, diagnostics and basic research. The Company’s solutions include research use only (RUO) proteomic tools and antibody development for clinical application. The RUO proteomic products include protein binding reagents, such as antibodies and immunoassays, and related reagents. The Company’s products are used by researchers to study biological pathways, which is critical for scientific research, diagnostics and drug discovery. The Company serves scientists and researchers in academic institutions, research institutes and pharmaceutical, biotechnology and diagnostics companies.

Contact details

Address:
Discovery Drive
Cambridge Biomedical Campus, Hills Road
CAMBRIDGE
CB20AX
United Kingdom
Telephone:
+44 (01223) 696000
Website:
www.abcam.com/

Important dates

Future events
There are no future events available.
Past events
Interim results 08 March 2021 08/03/21
Trading Announcement 11 January 2021 11/01/21
AGM 04 December 2020 04/12/20
Annual report 03 November 2020 03/11/20
Final results 14 September 2020 14/09/20
Trading Announcement 23 July 2020 23/07/20

General stock information

EPIC:
ABC
ISIN:
GB00B6774699
Market cap:
£3.30 billion
Shares in issue:
226.72 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
FTSE AIM 100,FTSE AIM All Share

Key personnel

  • Alan Hirzel
    Chief Executive Officer, Executive Director
  • Michael Baldock
    Chief Financial Officer, Executive Director
  • Marc Perkins
    Associate General Counsel and Interim Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.